Cargando…
P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED?
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429482/ http://dx.doi.org/10.1097/01.HS9.0000969680.24060.be |
| _version_ | 1785090724808622080 |
|---|---|
| author | Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor |
| author_facet | Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor |
| author_sort | Huber, Sandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429482 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294822023-08-17 P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429482/ http://dx.doi.org/10.1097/01.HS9.0000969680.24060.be Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Huber, Sandra Baer, Constance Hutter, Stephan Dicker, Frank Meggendorfer, Manja Pohlkamp, Christian Kern, Wolfgang Haferlach, Torsten Haferlach, Claudia Hoermann, Gregor P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? |
| title | P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? |
| title_full | P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? |
| title_fullStr | P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? |
| title_full_unstemmed | P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? |
| title_short | P694: RISK ASSESSMENT ACCORDING TO IPSS-M IS SUPERIOR TO AML ELN 2022 RISK CLASSIFICATION IN MDS/AML PATIENTS DEFINED BY ICC – IS AN INCLUSION INTO AML TRIALS JUSTIFIED? |
| title_sort | p694: risk assessment according to ipss-m is superior to aml eln 2022 risk classification in mds/aml patients defined by icc – is an inclusion into aml trials justified? |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429482/ http://dx.doi.org/10.1097/01.HS9.0000969680.24060.be |
| work_keys_str_mv | AT hubersandra p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT baerconstance p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT hutterstephan p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT dickerfrank p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT meggendorfermanja p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT pohlkampchristian p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT kernwolfgang p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT haferlachtorsten p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT haferlachclaudia p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified AT hoermanngregor p694riskassessmentaccordingtoipssmissuperiortoamleln2022riskclassificationinmdsamlpatientsdefinedbyiccisaninclusionintoamltrialsjustified |